Patents by Inventor Daniel Hohl

Daniel Hohl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction
    Patent number: 7691808
    Abstract: Disclosed herein are compositions and methods for the treatment or prevention of neurological disorders. Also disclosed are compositions and methods for the treatment or prevention of skin pathologies. The invention further discloses compositions and methods for the modulation of acetylcholine receptor activity. Antibodies generated against SLURP-1 and related proteins are also included.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: April 6, 2010
    Assignee: Merck Serono SA
    Inventors: Fabrice Chimienti, Ronald Hogg, Marcel Huber, Daniel Bertrand, Daniel Hohl
  • Slurp-1 compositions and methods of use thereof
    Publication number: 20070219130
    Abstract: Disclosed herein are compositions and methods for the treatment or prevention of neurological disorders. Also disclosed are compositions and methods for the treatment or prevention of skin pathologies. The invention further discloses compositions and methods for the modulation of acetylcholine receptor activity. Antibodies generated against SLURP-1 and related proteins are also included.
    Type: Application
    Filed: September 6, 2006
    Publication date: September 20, 2007
    Inventors: Fabrice Chimienti, Ronald Hogg, Marcel Huber, Daniel Bertrand, Daniel Hohl
  • Use of SLURP-1 compositions for treating schizophrenia
    Patent number: 7135454
    Abstract: Disclosed herein are compositions and methods for the treatment or prevention of neurological disorders. Also disclosed are compositions and methods for the treatment or prevention of skin pathologies. The invention further discloses compositions and methods for the modulation of acetylcholine receptor activity. Antibodies generated against SLURP-1 and related proteins are also included.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: November 14, 2006
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Fabrice Chimienti, Ronald Hogg, Marcel Huber, Daniel Bertrand, Daniel Hohl
  • SLURP-1 compositions and methods of use thereof
    Publication number: 20050004025
    Abstract: Disclosed herein are compositions and methods for the treatment or prevention of neurological disorders. Also disclosed are compositions and methods for the treatment or prevention of skin pathologies. The invention further discloses compositions and methods for the modulation of acetylcholine receptor activity. Antibodies generated against SLURP-1 and related proteins are also included.
    Type: Application
    Filed: April 16, 2004
    Publication date: January 6, 2005
    Inventors: Fabrice Chimienti, Ronald Hogg, Marcel Huber, Daniel Bertrand, Daniel Hohl